CovidDB: The Covid-19 Inpatient Database
NCT04344171 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2020-04-21
Summary
The aim of the project is to better understand the Covid-19 inpatient course of the disease and to quickly identify the positive experiences in the treatment in order to update guidelines for the treatment and use of medication.
Conditions
Sponsors & Collaborators
-
ClarData
lead OTHER
Principal Investigators
-
Julia Ferencz, MD · ClarData
-
Hans-Rudolf Tinneberg, Prof. · University of Giessen
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-30
- Primary Completion
- 2022-12-31
- Completion
- 2023-06-30
Countries
- Germany
- Romania
Study Locations
More Related Trials
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886 ·Status: COMPLETED
-
Observational, Prospective Clinical Study to Evaluate Biomarkers as Indicators of Acute Bacterial or Viral Infections
NCT01917461 ·Status: COMPLETED
-
Immunological Profiling of Patients With COVID-19 in Respiratory Distress
NCT04351711 ·Status: COMPLETED
-
A COVID-19 Symptom, Exposure and Immune Response Registry
NCT04348942 ·Status: COMPLETED
-
Institutional Registry on Outpatient and Hospitalized COVID-19 Infected Patients
NCT04839107 ·Status: UNKNOWN
-
Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain
NCT04355871 ·Status: COMPLETED
-
Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19
NCT04456075 ·Status: UNKNOWN
-
Cohort of the Specialist Network Infectious Diseases
NCT06879184 ·Status: NOT_YET_RECRUITING
-
NoRCoRP Assessment Clinic
NCT04710836 ·Status: COMPLETED
-
A Prospective "Universal" Observational Database for COVID-19
NCT04347993 ·Status: COMPLETED
-
Mechanisms for Covid-19 Disease Complications
NCT04314232 ·Status: UNKNOWN
-
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
NCT04952337 ·Status: UNKNOWN
-
Assesment of the Metabolomic Signature in COVID-19 Patients
NCT04497272 ·Status: COMPLETED ·Phase: NA
-
Clinical and Biological Predictors of COVID-19 Disease in Older Patients
NCT04348396 ·Status: RECRUITING
-
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662 ·Status: UNKNOWN
-
National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19
NCT04343781 ·Status: COMPLETED
-
The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications
NCT04453748 ·Status: UNKNOWN
-
Prospective Multidisciplinary Post-COVID-19 Registry Tyrol
NCT05545332 ·Status: RECRUITING
-
Analysing the French COVID-19 Epidemic Using a National SARS-CoV-2 RT-PCR Database
NCT04738331 ·Status: UNKNOWN
-
Caracterisation of COVID-19 Patients Hospitalized in Infectious Disease Department
NCT04779021 ·Status: UNKNOWN
-
Collection of Biological Samples With Clinical Characterization of Covid-19 Patients
NCT04363385 ·Status: TERMINATED ·Phase: NA
-
Characteristics of Long COVID-19 Syndrome
NCT04793269 ·Status: ACTIVE_NOT_RECRUITING
-
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
NCT04324047 ·Status: UNKNOWN
-
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373 ·Status: UNKNOWN